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SUMMARY
The antifungal activities of fluconazole, itraconazole, ketoconazole, terbinafine and griseofulvin were tested by broth microdilution 
technique, against 60 dermatophytes isolated from nail or skin specimens from Goiania city patients, Brazil. In this study, the microtiter 
plates were incubated at 28 oC allowing a reading of the minimal inhibitory concentration (MIC) after four days of incubation for 
Trichophyton mentagrophytes and five days for T. rubrum and Microsporum canis. Most of the dermatophytes had uniform patterns 
of susceptibility to the antifungal agents tested. Low MIC values as 0.03 µg/mL were found for 33.3%, 31.6% and 15% of isolates 
for itraconazole, ketoconazole and terbinafine, respectively. 
KEYWORDS: Dermatophytes; Broth microdilution method; Minimal Inhibitory Concentration.
INTRODUCTION
Dermatophytosis, mycotic infections caused by dermatophytes, 
are commonly related in tropical countries and represent an important 
public health problem yet unresolved4. Trychophyton rubrum, T. 
mentagrophytes and Microsporum canis are the most common species 
isolated in Brazil as causative agents of dermatophytosis1,6,7,8,21. 
In Goiania city, Brazil, these same etiological agents have been 
recovered in studies of COSTA et al.6,7. Antifungal agents such as 
triazoles (itraconazole, fluconazole), imidazole (ketoconazole), 
allylamine (terbinafine) and griseofulvin have been reported to have 
substantial activity in dermatophytosis16,17. However, infections due 
to dermatophytes are often associated with relapses after cessation 
of therapy20. By the way, in vitro antifungal susceptibility tests could 
help to optimize the therapy and to select an effective antifungal agent 
for this mycosis3. A standard method for susceptibility testing of 
dermatophytes is lacking, but good results of MIC using either broth 
macrodilution or broth microdilution tests have been obtained in several 
reports9,10,12,18. The purpose of this work was to establish the in vitro 
antifungal susceptibility of fluconazole, itraconazole, ketoconazole, 
terbinafine and griseofulvin against clinical dermatophytes isolated in 
Goiania-GO, Brazil, using the broth microdilution method.
MATERIALS AND METHODS
Organisms: A total of 60 dermatophyte strains, including 
Trichophyton rubrum (n = 27), T. mentagrophytes (n = 14) and 
Microsporum canis (n = 19) were tested. All microorganisms were 
clinical isolates obtained from nail or skin specimens recovered from 
patients from Goiania University Hospital from March to July 2006. 
The fungi were maintained in sterile distilled water at room temperature 
and prior to testing, the strains were subcultured on potato dextrose agar 
(PDA) at 28 oC for seven to 15 days to ensure the viability and the purity 
of the inoculum. Candida parapsilosis ATCC 22019 was included as 
reference strain.
In vitro susceptibility testing: The broth microdilution assay for 
antifungal susceptibility testing of dermatophytes was performed, when 
possible according to the CLSI guidelines in the document M38-A of 
filamentous fungi5.
Antifungal drugs dilution: The drugs were obtained from their 
respective manufacturers: fluconazole (Pfizer International, New York, 
NY), ketoconazole, itraconazole (Jansen Pharmaceuticals, Beerse, 
Belgium), terbinafine (Novartis Research Institute, Vienna, Austria) and 
griseofulvin (Sigma Chemical Company, St. Louis, Mo). Fluconazole 
was dissolved in distilled water while the other drugs were dissolved 
in 100% dimethyl sulfoxide (Sigma-Aldrich). They were subsequently 
prepared as stock solution and serial twofold dilutions were performed. 
Final concentrations ranged from 0.125 to 64 µg/mL for fluconazole, 
0.03 to 16 µg/mL for ketoconazole, itraconazole and terbinafine, and 
0.03 to 8 µg/mL for griseofulvin.
Test procedure: Inoculum suspensions of dermatophytes were 
prepared from the seven days cultures grown on potato dextrose agar 
at 28 oC. The fungal colonies were covered with approximately 10 
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mL of distilled water, and the suspensions were made by scraping the 
surface with the tip of a sterile loop. The resulting mixture of conidia 
and hyphal fragments was withdrawn and transferred to sterile tubes 
and left for 15 to 20 minutes at room temperature to sediment the heavy 
particles. The optical density of the suspensions containing conidia and 
hyphal fragments was read at 530 nm, adjusted to transmittance of 65 
to 70% (∼ 2 to 4 X 106 cells/mL) and diluted with RPMI 1640 medium 
(Sigma Chemical Co., St. Louis, Mo) to obtain the final inoculum size 
of approximately 0.4 to 5 X 104 cells/mL. Aliquots of 100 µL of these 
suspensions were inoculated in well of microtiter plate containing 100 
µL of specific antifungal drug concentration and incubated at 28 oC. Each 
assay was carried out in duplicate.
Endpoint determination: Endpoint determination values were 
performed visually every 24 h until the indication of growth in control 
well drug-free. For azole agents and griseofulvin, the MIC was defined 
as the lowest concentration that produced prominent inhibition of growth 
(approximately 80% inhibition) while for terbinafine, was defined as 
lowest concentration showing 100% growth inhibition23.
RESULTS
MICs of antifungal agents for 60 dermatophytes isolates could be 
determined after four days for T. mentagrophytes and five days for T. 
rubrum and M. canis when incubated at 28 oC.
In general, the species of dermatophytes showed similar patterns of 
susceptibility to each antifungal agent tested. The determination of the 
isolates as susceptible or resistant is complex and not yet been established 
for dermatophytes, but high MIC values were found for some isolates. 
Seven (11.6%) dermatophytes strains (five T. rubrum and two M. canis) 
had MICs of fluconazole of 32 µg/mL, five (8.3%) strains (four T. rubrum 
and one M. canis) had MICs of ketoconazole of 4 µg/mL and one M. 
canis isolate had MIC of 8 µg/mL for griseofulvin. However most isolates 
showed low MIC values, being that 33.3%, 31.6% and 15% of isolates 
had MIC of 0.03 µg/mL for itraconazole, ketoconazole and terbinafine, 
respectively.
Table 1 summarizes the MIC ranges, concentrations inhibiting 50% 
(MIC50) and 90% (MIC90) of the isolates and geometric mean of the MICs 
of the five antifungal drugs against 60 strains of dermatophytes.
The MIC ranges of fluconazole, itraconazole and ketoconazole for 
C. parapsilosis ATCC 22019 were within the values standardized by 
CLSI document M-38-A.
DISCUSSION
The determination of the in vitro susceptibility may prove helpful to 
predict the ability of a given antifungal agent to eradicate dermatophytes. 
Although a reference method for dermatophytes, is not available, a good 
correlation between the in vitro data, using broth microdilution method, 
and clinical outcome has been demonstrated19. 
Some recommendations, as temperature and duration of incubation 
used in the broth microdilution method according with the document M 
Table 1
In vitro activities of five antifungal agents against 60 strains of dermatophytes isolated from patients from Goiania University Hospital from March to July 2006
Species  
(No. of isolates)
Antifungal agents MIC (µg/mL)
Range MIC50 MIC90 Geometric mean
T. rubrum Fluconazole 2-32 8 32 7.60
(27) Itraconazole 0.03-4 0.125 0.5 0.10
Ketoconazole 0.03-4 0.06 4 0.13
Terbinafine 0.03-0.5 0.125 0.25 0.11
Griseofulvin 0.25-2 0.5 1 0.65
T. mentagrophytes Fluconazole 4-16 16 16 11.31
(14) Itraconazole 0.03-0.25 0.125 0.25 0.09
Ketoconazole 0.03-1 0.125 0.25 0.12
Terbinafine 0.03-0.5 0.06 0.25 0.08
Griseofulvin 0.25-1 0.5 0.5 0.45
M. canis Fluconazole 2-32 8 16 9.96
(19) Itraconazole 0.03-0.25 0.125 0.25 0.08
Ketoconazole 0.03-4 0.125 0.25 0.12
Terbinafine 0.03-1 0.125 0.25 0.11
Griseofulvin 0.06-8 0.25 0.5 0.31
MIC - minimal inhibitory concentration; MIC50 and MIC90 - MIC inhibiting 50% and 90% of the isolates
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38-A of filamentous fungi were modified in this study. In this document, 
the temperature at 35 oC is used for incubation; however we used for 
dermatophytes the temperature at 28 oC according to BARROS et al.2 and 
SANTOS et al.23 which obtained success in their results. Studies of in 
vitro susceptibility testing for dermatophytes previously performed in our 
laboratory showed that the MIC values were easier to read and to interpret 
(a good visualization of the growth) when the microtiter plates were 
incubated at 28 oC than at 35 oC (data not shown). It is well known that an 
optimal growth on culture media is obtained by dermatophytes strains when 
incubated between 28 oC and 30 oC9,11,22. The document M38-A establish 
24 to 72 h of incubation for filamentous fungi, however, in our work, a 
detectable growth was observed after four days for T. mentagrophytes 
and after five days for T. rubrum and M. canis. The ideal incubation time 
is still a matter of debate. FERNÁNDEZ-TORRES et al.13 , SANTOS et 
al.23,24 found that seven days was sufficient to observe prominent growth 
in control wells, while GHANNOUM et al.14 and JESSUP et al.18 verified 
growth in four days at 28 oC.
In our work, the evaluation of in vitro susceptibility showed that 
the antifungal drugs tested, with exception of fluconazole, displayed 
good activity against the dermatophytes. It is worth mentioning that 
itraconazole, ketoconazole and terbinafine had the lowest MIC values 
and geometric means. Similar results have been verified by other authors 
that showed that these drugs had low MICs against dermatophytes10,12,15. 
These low MICs found for the three drugs can help to explain the 
promising results obtained for the treatment of dermatophytosis with 
these antifungal agents19.
Although fluconazole has showed the highest MIC values of all the 
antifungal agents tested, we verified that T. rubrum strains, one specie that 
cause a recalcitrant chronic disease, were more susceptible to this drug 
than T. mentagrophytes and M. canis isolates (geometric mean of 7.60 
for T. rubrum, 9.96 for M. canis and 11.31 for T. mentagrophytes). Our 
results are similar to FERNÁNDEZ-TORRES et al.10 who demonstrated 
higher activity of fluconazole for T. rubrum than for T. mentagrophytes, 
M. canis and M. gypseum.
In summary, the parameters as temperature at 28 oC, incubation 
time of five days and inoculum of 0.4 to 5 X 104 cells/mL allowed the 
determination of MIC for dermatophytes by using the microdilution 
method. Besides, our work demonstrated that in vitro different antifungal 
agents are active against dermatophytes independent of specie. 
RESUMO
Teste de suscetibilidade in vitro de dermatófitos isolados em 
Goiânia, Brasil, contra cinco agentes antifúngicos pelo método de 
microdiluição em caldo
Atividades antifúngicas de fluconazol, itraconazol, cetoconazol, 
terbinafina e griseofulvina foram testadas pelo método de microdiluição 
em caldo contra 60 isolados de dermatófitos. Os resultados mostraram 
que todos os isolados produziram crescimento claramente detectável a 
28 oC e a concentração inibitória mínima (CIM) foi determinada após 
quatro dias de incubação para Trichophyton mentagrophytes e cinco 
dias para T. rubrum e Microsporum canis. A maioria dos isolados teve 
um padrão uniforme de suscetibilidade para os agentes antifúngicos 
testados. Baixos valores de CIM como 0,03 µg/mL foram encontrados 
para 33,3%, 31,6% e 15% dos isolados para itraconazol, cetoconazol e 
terbinafina, respectivamente. 
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